Protocol No: ECCT/26/08/01 Date of Protocol: 18-08-2026
Status: Approved Date Approved: 22-10-2026

Study Title:

A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Metformin in Adults with Prediabetes in Kenya

Study Objectives:

To evaluate the efficacy and safety of oral metformin 500 mg compared with placebo in preventing or delaying the progression from prediabetes to type 2 diabetes in adults.

Laymans Summary:

This study will assess whether metformin, a medicine commonly used to control blood sugar, can help prevent or delay the development of diabetes in adults with prediabetes. Participants will receive either metformin 500 mg tablets or a matching placebo and will be monitored throughout the study for effectiveness and safety.

 

Abstract of Study:

This randomized, controlled clinical trial will evaluate the efficacy and safety of oral metformin 500 mg in adults with prediabetes in Kenya. Eligible participants will be randomly assigned to receive either metformin or a matching placebo. The study will assess changes in blood glucose levels and the progression from prediabetes to diabetes, while monitoring participants for adverse events. The findings will help determine the potential role of metformin in preventing or delaying the onset of type 2 diabetes among adults with prediabetes.